CD8A and cancer: Monitoring chemokine concentrations in peripheral blood and changes in the ratio of CD4+ T and CD8+ T cells could indicate an improvement in the immune status of cancer patients, which may be useful for evaluating the efficacy of tumor treatment in the future.